tiprankstipranks
Sinopharm Reports Mixed Mid-Year Financials
Company Announcements

Sinopharm Reports Mixed Mid-Year Financials

Sinopharm Group Co (HK:1099) has released an update.

Don't Miss our Black Friday Offers:

Sinopharm Group Co. Ltd. has released its preliminary financial results for the first half of 2024, revealing a slight decrease in revenue and a notable decline in profits compared to the same period last year. Despite a 1.57% dip in revenue and a decrease in operating and total profits by over 25%, the company’s total assets increased by 8.06%, and net assets per share saw a marginal growth.

For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSinopharm Group Reports Nine-Month Financial Results
TipRanks HongKong Auto-Generated NewsdeskSinopharm Group Co. Reports Mixed Financial Results
TipRanks HongKong Auto-Generated NewsdeskSinopharm Group’s Asset Growth Boosts Investor Confidence
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App